Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Oncology

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    October 2018
  1. THULEAU A, Gilbert C, Bauer P, Alran S, et al
    A New Transcutaneous Method for Breast Cancer Detection with Dogs.
    Oncology. 2018 Oct 2:1-4. doi: 10.1159/000492895.
    PubMed     Text format     Abstract available


    September 2018
  2. MUTAI R, Goldvaser H, Shochat T, Peretz I, et al
    Prognostic Value of the Detection of Lymphovascular Invasion in Hormone Receptor-Positive Early Breast Cancer in the Era of Molecular Profiling.
    Oncology. 2018 Sep 25:1-11. doi: 10.1159/000492429.
    PubMed     Text format     Abstract available


    June 2018
  3. BAE SY, Jung SP, Jung ES, Park SM, et al
    Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
    Oncology. 2018 Jun 18:1-7. doi: 10.1159/000488944.
    PubMed     Text format     Abstract available


    May 2018
  4. CORSO G, Maisonneuve P, Santomauro GI, De Scalzi AM, et al
    Ipsilateral Breast Tumor Reappearance and Contralateral Breast Cancer after Primary Breast Cancer Treatment: A Comprehensive Retrospective Study of 15,168 Patients.
    Oncology. 2018 May 30:1-9. doi: 10.1159/000488764.
    PubMed     Text format     Abstract available


  5. LANDRY S, Chasles G, Pointreau Y, Bourgeois H, et al
    Influence of an Adapted Physical Activity Program on Self-Esteem and Quality of Life of Breast Cancer Patients after Mastectomy.
    Oncology. 2018 May 30:1-4. doi: 10.1159/000489265.
    PubMed     Text format     Abstract available


    January 2018
  6. LEE SJ, Lee J, Kim WW, Jung JH, et al
    Del-1 Expression as a Potential Biomarker in Triple-Negative Early Breast Cancer.
    Oncology. 2018 Jan 31. pii: 000485658. doi: 10.1159/000485658.
    PubMed     Text format     Abstract available


  7. JIA S, Miedel MT, Ngo M, Hessenius R, et al
    Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes.
    Oncology. 2018;94:176-189.
    PubMed     Text format     Abstract available


  8. ISHITOBI M, Fukui R, Hashimoto Y, Kittaka N, et al
    pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery.
    Oncology. 2018;94:12-18.
    PubMed     Text format     Abstract available


  9. GIORDANO G, Febbraro A, Quaquarini E, Turletti A, et al
    Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports.
    Oncology. 2018;94 Suppl 1:34-44.
    PubMed     Text format     Abstract available


  10. CATANIA G, Malaguti P, Gasparro S, Cognetti F, et al
    Activity of Eribulin Mesylate in Brain Metastasis from Breast Cancer: A Stone in a Pond?
    Oncology. 2018;94 Suppl 1:29-33.
    PubMed     Text format     Abstract available


  11. DE SANCTIS R, Agostinetto E, Masci G, Ferraro E, et al
    Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients.
    Oncology. 2018;94 Suppl 1:19-28.
    PubMed     Text format     Abstract available


  12. NETTUNO R, Menditto C
    Eribulin as a Feasible and Safe Monotherapy in a Dialytic Pretreated Woman with Metastatic Breast Cancer: A Case Report.
    Oncology. 2018;94 Suppl 1:16-18.
    PubMed     Text format     Abstract available


  13. PEDERSINI R, Vassalli L, Claps M, Tulla A, et al
    Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study.
    Oncology. 2018;94 Suppl 1:10-15.
    PubMed     Text format     Abstract available


  14. MEDICI M, Fossile E
    Long-Term Response with Eribulin Mesylate in a Breast Cancer Patient: A Case Report.
    Oncology. 2018;94 Suppl 1:3-5.
    PubMed     Text format     Abstract available


  15. DOTTORINI L, Catena L, Sarno I, Di Menna G, et al
    Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement.
    Oncology. 2018;94 Suppl 1:6-9.
    PubMed     Text format     Abstract available


  16. RESENDE U, Cabello C, Oliveira Botelho Ramalho S, Zeferino LC, et al
    Predictors of Pathological Complete Response in Women with Clinical Complete Response to Neoadjuvant Chemotherapy in Breast Carcinoma.
    Oncology. 2018;95:229-238.
    PubMed     Text format     Abstract available


    November 2017
  17. KAWAHARA T, Shimozuma K, Shiroiwa T, Hagiwara Y, et al
    Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer.
    Oncology. 2017 Nov 17. doi: 10.1159/000484142.
    PubMed     Text format     Abstract available


  18. HOKIMOTO N, Sugimoto T, Namikawa T, Funakoshi T, et al
    A Novel Color Fluorescence Navigation System for Intraoperative Transcutaneous Lymphatic Mapping and Resection of Sentinel Lymph Nodes in Breast Cancer: Comparison with the Combination of Gamma Probe Scanning and Visible Dye Methods.
    Oncology. 2017 Nov 10. doi: 10.1159/000484050.
    PubMed     Text format     Abstract available


    September 2017
  19. GAL O, Ishai Y, Sulkes A, Shochat T, et al
    Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term Outcome.
    Oncology. 2017 Sep 27. doi: 10.1159/000480087.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: